Wijermans P. et al. 2000
Wijermans P., Lubbert M., Verhoef G., Bosly A., Ravoet C, Andre M., and Ferrant A., 2000. Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients. J. Clin. Oncol. 18: 956-962.
